Browse 13 Pharmaceutical companies funded by Lux Capital. See funding amounts, founder contacts, and investment details.
Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.
Multiply Labs develops robotic systems for automating biologics manufacturing.
TriGemX Bio uses the science of gut-brain biology to create medicines that transform human health.
Enveda discovers medicines by studying the chemistry of nature and translating natural compounds into potential therapeutic candidates.
Resilience is a biomanufacturing company that provides access to complex medicines and protects biopharmaceutical supply chains.
Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.
Atrandi Biosciences is a Lithuanian biotech startup that aims to commercialize droplet microfluidics technology.
Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.
Anagenex is a seed stage biotechnology company building a novel platform for drug discovery focusing on difficult targets.
Enveda Biosciences is a biotechnology company that develops novel medications derived from plants.
Kallyope uses the science of gut-brain biology to create medicines that transform human health.
A clinical stage drug development company who aims to invent novel drugs for hard-to-treat diseases using its proprietary AI platform
Capella Bioscience engages in the discovery and development of monoclonal antibodies.
View all companies funded by Lux Capital across every industry and funding stage.
View Full Lux Capital Portfolio